MT3 and breast cancer: The final variant, rs410155, is located between two metallothionein genes, MT3 and MT4. While MT4 has not been associated with breast cancer, MT3 is overexpressed in breast cancer cells, which is associated with increased invasiveness and higher concentrations of matrix metallopeptidase 330,31.